Animal Health Market is expected to reach USD 86 billion by 2030, in comparison to the market valued at USD 45.8billion in 2020. The market is expected to grow CAGR by approximately 6.5%.The global animal health market has shown tremendous growth in recent years due to the increase in the adoption of a pet, an increase in large consumption of meat and milk. The market is also growing because of the rise in protein-based foods and an increase in foodborne diseases globally. The sudden increase in demand for meat and animal-based food products have lead the pharma companies to produce advanced vaccines and pharmaceuticals. This has brought significant growth for the companies also to put efforts into preparing drugs for animals which can control pathogen contamination and foodborne diseases.

Market Segmentation:

The global animal health market is segmented by Product into Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Inactivated Vaccines, and Others. The market is segmented By Feed Additives into (Antibiotics and Prebiotics & probiotics). The antibiotics are further subdivided into Vitamins, Amino acids, Feed, enzymes, and Antioxidants.  The Prebiotics & probiotics are subdivided into Minerals, Diagnostics, Instruments, Consumables, and Others. BY Pharmaceuticals the animal health market is categorized into Parasiticides, Anti-infectives, Anti-inflammatory, Analgesics, and Others. By Distribution channel the market is segregated into Retail, E-commerce, Veterinary Hospitals & Clinics. By end-users, the market is classified into Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics, and Others. By geography, the animal health market is bifurcated into Latin America, North America, Asia Pacific, Europe, and the Middle East & Africa. 

Market Dynamics and Factors:

The global animal health market is driven by technological advancement include the modernization of efficient management systems, animal owner mobile technology, and vaccine bank. Also, the high inclination of government health care organizations toward the enhancement of agricultural practices and animal health is presumed to be responsible for the growth of this segment. However, due to the lack of technological advancement in other regions is one of the major factors of slow growth of the market. Advancement of Retail channels and e-commerce platforms will account for significant growth in the animal health market.

Geographic Analysis:

Asia Pacific is expected to grow at a steady rate due to the result of high clinical urgency to control the incidence of zoonotic diseases and the management of disease outbreaks, such as swine influenza and Ebola. Asia Pacific is expected to exhibit lucrative growth over the coming years as a result of consistent R&D investments deployed by prominent players and their efforts to advertise branded and generic therapeutics at a relatively inexpensive price. North America captured substantial share in the global market in 2019, owing to a wide range of definitive measures adopted by welfare organizations, technological advancements, a rising number of zoonotic diseases, and an increasing number of pet owners.

Competitive Scenario:

The major players in global animal health Market are Zoetis Inc., Boehringer Ingelheim Animal Health, Merck Animal Health, Elanco, Bayer AG, Ceva Sante Animale S.A., Virbac SA, Vetoquinol SA, IDEXX Laboratories, Inc., and Covetrus, Inc.

Animal Health Market Report Scope